Area of research
Molecular Biology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Fibroblast Growth Factor Research, Prostate Cancer Treatment and Research, Bladder and Urothelial Cancer Treatments, and Radiopharmaceutical Chemistry and Applications.
Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study
Tumor agnostic efficacy and safety of erdafitinib (erda) in patients (pts) with advanced solid tumors with prespecified <i>FGFR</i> alterations (<i>FGFRalt</i>): RAGNAR primary analysis.
Tumor agnostic efficacy and safety of erdafitinib in patients (pts) with advanced solid tumors with prespecified fibroblast growth factor receptor alterations (<i>FGFRalt</i>) in RAGNAR: Interim analysis (IA) results.
Erdafitinib in pediatric patients with advanced solid tumors with fibroblast growth factor receptor (<i>FGFR</i>) gene alterations: RAGNAR study pediatric cohort.
Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma
Population Pharmacokinetic Analysis of Abiraterone in Chemotherapy-Naïve and Docetaxel-Treated Patients with Metastatic Castration-Resistant Prostate Cancer
The association between body composition and toxicities from the combination of Doxil and trabectedin in patients with advanced relapsed ovarian cancer